Consensus Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Market Closed - Japan Exchange 02:00:00 2024-05-29 EDT 5-day change 1st Jan Change
4,113 JPY -0.92% Intraday chart for Takeda Pharmaceutical Company Limited +0.27% +1.46%

Evolution of the average Target Price on Takeda Pharmaceutical Company Limited

Price target over the last 5 years

History of analyst recommendation changes

6b39f4.ZUd9Y4g8glFUV4DlTYdqK-HF5Od-IPiV97R2ObRsEMI.Cj9MV-F46R4hP8uGG78ZTdH0q6Abd8nRrs1Af9AtVO8cBhMv5l66IDo84w~39a2e7d503aec7ab94f0ec64ac16a8cf
Toyota becomes Asia's most shorted large-cap stock - Hazeltree RE
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy MT
Japanese Shares Hit 33,000 Mark Again as Yen Slips, BoJ Holds Rates Steady MT
Brazil's consumer prices forecast to have risen faster in Sept - Reuters poll RE
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating MT
BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20 MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy MT
Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy MT
Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform MT
TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight MT
Japan Petroleum Exploration : Japanese shares end higher on Wall Street gains, stable U.S. rates RE
Japanese shares fall on profit booking, checking U.S. rates RE
Takeda Pharmaceutical : Says Phase 3 Study Results Show Takhzyro Curbed HAE Attack Rate Long Term MT
Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year EQ
Takeda Pharmaceutical : Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year BU
Takeda Pharmaceutical : Announces Execution of Loan Agreement in Connection with Proposed Acquisition of Shire plc BU
Takeda Pharmaceutical : Announces Execution of Senior Short Term Loan Facility Agreement and Subordinated Syndicated Loan Agreement and Second Amendment to Bridge Credit Agreement in Connection with Proposed Acquisition of Shire plc BU
BAYER : Germany's Merck hires JP Morgan to sell consumer health RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,151 JPY
Average target price
4,801 JPY
Spread / Average Target
+15.67%
High Price Target
5,600 JPY
Spread / Highest target
+34.91%
Low Price Target
4,200 JPY
Spread / Lowest Target
+1.18%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Takeda Pharmaceutical Company Limited

Jefferies & Co.
TD Cowen
BofA Securities
Cowen
Morgan Stanley
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. 4502 Stock
  4. Consensus Takeda Pharmaceutical Company Limited